Concurrent Zrsr2 Mutation and Tet2 Loss Promote Myelodysplastic Neoplasm in Mice

Using CRISPR/Cas9 genetically engineered mice, investigators demonstrated that Zrsr2m/mTet2−/− promoted myelodysplastic neoplasm with reduced penetrance.